Life Sciences

Scorpion Secures $150M in Series C Funding to Expand Ca...

Scorpion Therapeutics has raised $150M to strengthen its clinical pipeline by ad...

House Committee Orders FDA to Halt Regulation Governing...

The FDA has been instructed by lawmakers to halt the implementation of its final...

Sionna Pens Deal With AbbVie For Cystic Fibrosis Drugs

Sionna Therapeutics has swiftly found a way to put part of its $182 million seri...

Meilleur Technologies, Creator of PET Tests for Alzheim...

With the acquisition of Meilleur Technologies, Lantheus is expanding its portfol...

Covid Symptoms Prevented by New Drug Used on Mice, No R...

Research findings from new studies show that organ damage resulting from Covid-1...

Backed by Novo Holdings, Asceneuron Raises $100 Million...

Alzheimer’s drugs have been flooding the market lately, as investors look for th...

Autoimmune-Stricken Patients Respond to Allogeneic CAR-...

Three patients with autoimmune disorders have responded favorably to allogeneic ...

Myricx Bio Raises $114M in Series A Funding to Advance ...

Antibiotic-drug conjugates (ADCs) are a highly competitive biologics segment. Th...

Beacon Raises $170M Series B For Eye Disease Candidates

Beacon Therapeutics has secured $170 million in Series B funding, which the gene...

After a Two-Year Recall, Roche Set to Relaunch Eye Impl...

Susvimo was halted by Roche in mid-2022 due to manufacturing issues that prompte...

Mesoblast Resubmits BLA For Ryoncil Approval

The globally recognized allogeneic cellular therapy developer, Mesoblast Limited...

Roche Stops Lung Cancer Immunotherapy Trial in Newest D...

The management of Roche has decided to stop the immunotherapy treatment trial fo...

Pentixapharm Acquires Glycotope for its target discover...

In a bid to amp up its radiopharmaceuticals pipeline, Pentixapharm has chosen to...

European Regulatory Agency Gives AstraZeneca’s Covid-19...

Despite having exited the COVID-19 vaccine market this year, pharma giant AstraZ...

Sanofi’s Dupixent Injectable Approved by the EU to Trea...

Sanofi and Regeneron gained approval from the European Union for expanded use of...

Deal on Cancer ADC Gets Canceled by Eisai and Bristol M...

Eisai will terminate a partnership on a dual-action lung and ovarian cancer medi...